Effects of sitagliptin beyond glycemic control: focus on quality of life.
Sakamoto Y, Oyama J, Ikeda H, Kuroki S, Gondo S, Iwamoto T, Uchida Y, Kodama K, Hiwatashi A, Shimomura M, Taguchi I, Inoue T, Node K; S-DOG investigators.
Sakamoto Y, et al.
Cardiovasc Diabetol. 2013 Feb 21;12:35. doi: 10.1186/1475-2840-12-35.
Cardiovasc Diabetol. 2013.
PMID: 23432786
Free PMC article.